Curanex Pharmaceuticals Files 8-K
Ticker: CURX · Form: 8-K · Filed: 2026-04-02T08:20:25-04:00
Sentiment: neutral
Topics: 8-K, disclosure, financial-exhibits
TL;DR
Curanex Pharma dropped an 8-K, check the exhibits for the latest news.
AI Summary
Curanex Pharmaceuticals Inc. filed an 8-K on April 2, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). The filing includes an 8-K form, an exhibit (EX-99.1), and associated XBRL data. The company's mailing and business address is 2 Jericho Plaza, Suite 101B, Jericho, NY 11753.
Why It Matters
This filing indicates that Curanex Pharmaceuticals is making disclosures and providing financial exhibits, which could contain important updates for investors regarding the company's status.
Risk Assessment
Risk Level: low — This is a routine filing for an 8-K and does not appear to contain any immediate material adverse information.
Key Numbers
- 0002025942 — CIK Number (Identifies Curanex Pharmaceuticals Inc. in SEC filings.)
- 2026-04-02 — Filing Date (Date Curanex Pharmaceuticals Inc. filed this 8-K report.)
Key Players & Entities
- Curanex Pharmaceuticals Inc. (company) — Filer
- 0002025942 (company) — CIK Number
- 2026-04-02 (date) — Filing Date
- 2 Jericho Plaza, Suite 101B, Jericho, NY 11753 (address) — Mailing and Business Address
FAQ
What specific information is disclosed under Regulation FD?
The filing indicates Item 7.01 (Regulation FD Disclosure) but does not detail the specific information disclosed within this 8-K document itself; it would be found in the attached exhibits.
What types of financial statements or exhibits are included?
The filing lists 'Financial Statements and Exhibits' under Item 9.01 and includes EX-99.1 as an exhibit, along with XBRL data.
What is the company's CIK number?
The CIK number for Curanex Pharmaceuticals Inc. is 0002025942.
Where is Curanex Pharmaceuticals Inc. located?
The company's mailing and business address is 2 Jericho Plaza, Suite 101B, Jericho, NY 11753.
What is the filing date of this 8-K report?
The 8-K report was filed on April 2, 2026.
From the Filing
EDGAR Filing Documents for 0001493152-26-014815 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001493152-26-014815 Filing Date 2026-04-02 Accepted 2026-04-02 08:20:25 Documents 13 Period of Report 2026-04-02 Items Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K form8-k.htm iXBRL 8-K 39334 2 EX-99.1 ex99-1.htm EX-99.1 13370 3 GRAPHIC ex99-1_001.jpg GRAPHIC 2767 Complete submission text file 0001493152-26-014815.txt 227817 Data Files Seq Description Document Type Size 4 XBRL SCHEMA FILE curx-20260402.xsd EX-101.SCH 3029 5 XBRL LABEL FILE curx-20260402_lab.xml EX-101.LAB 34239 6 XBRL PRESENTATION FILE curx-20260402_pre.xml EX-101.PRE 22368 16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3377 Mailing Address 2 JERICHO PLAZA, SUITE101B JERICHO NY 11753 Business Address 2 JERICHO PLAZA, SUITE101B JERICHO NY 11753 718-673-6078 Curanex Pharmaceuticals Inc (Filer) CIK : 0002025942 (see all company filings) EIN. : 830741390 | State of Incorp.: NV | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-42815 | Film No.: 26830727 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)